Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -7.001% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1ccsc1/C=N/n1c(-c2ccco2)n[nH]c1=S
b Cn1nc(CC(=O)Nc2cccnc2N2CCOCC2)c2ccccc2c1=O
c CC(=O)NCCOc1ccc2oc3ccccc3c2c1
d CCC[C@@H](CNC)NC[C@H](Cc1ccccc1)NCCCCc1ccccc1
Answer: b. Cn1nc(CC(=O)Nc2cccnc2N2CCOCC2)c2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1nc(CC(=O)Nc2cccnc2N2CCOCC2)c2ccccc2c1=O
Cn1nc(CC(=O)Nc2cccnc2N2CCOCC2)c2ccccc2c1=O
2-(3-methyl-4-oxophthalazin-1-yl)-N-(2-morpholin-4-ylpyridin-3-yl)acetamide